The DOI matches its OpenAlex record; 26 of the 26 references it cites were found in a registry or an index.
Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
Abstract
Thirty-five patients with the lupus anticoagulant (LA) were followed up between 1975 and 1982. The most prevalent clinical manifestation occurring in these patients was thrombosis. Nineteen patients (54.3%) had a single or recurrent thrombotic episode. Fifteen patients (42.8%) had venous thrombosis, and arterial thrombosis manifested by stroke or transient ischemic attacks occurred in six patients. Bleeding occurred in only five patients, four of whom had severe thrombocytopenia, while no excessive bleeding was noted during 18 operative procedures. Various therapeutic regimens, including corticosteriods, nonsteroidal anti-inflammatory drugs, cytotoxic or immunosuppressive agents, had no effect on the presence of the LA in these patients. Anticoagulants were successful in the treatment and prevention of thrombotic episodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moncada, S., Higgs, E. A., & Vane, J. R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91655-5 · Cited by 882
Carreras, L., Machin, S., Deman, R., Defreyn, G., Vermylen, J., Spitz, B., & Van Assche, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.
Lafer, E. M., Rauch, J., Andrzejewski, C., Mudd, D., Furie, B., Furie, B., Schwartz, R. S., & Stollar, B. D. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.4.897 · Cited by 536
Acquired inhibitors of blood coagulation.
Feinstein, D., & Rapaport, S. I. (1972) · PubMed · Cited by 521
(1963) · PubMed · Cited by 512
Thrombosis in Patients with the Lupus Anticoagulant
MUEH, J. R., HERBST, K. D., & RAPAPORT, S. I. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-156 · Cited by 496
Cl, C. (1952) · Journal of Clinical Investigation · Cited by 482
A clinical study of the lupus anticoagulant
Schleider, M., Nachman, R., Jaffe, E., & Coleman, M. (1976) · Blood · doi:10.1182/blood.v48.4.499.499 · Cited by 470
FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT
Lubbe, W. F., Palmer, S. J., Butler, W. S., & Liggins, G. C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92141-4 · Cited by 422
Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent.
Gospodarowicz, D., Moran, J., Braun, D., & Birdwell, C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.4120 · Cited by 414
Cited by
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
“Although a direct causal role for antiphospholipid antibodies in thrombogenesis has not been proved, antiphospholipid antibodies appear to be markers of risk, given the substantially increased rate of thrombosis in patients with these antibodies (6-9, 21, 22).”
BackgroundAnticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Obstetric Complications Associated with the Lupus Anticoagulant
Branch, D. W., Scott, J. R., Kochenour, N. K., & Hershgold, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132104 · Cited by 560
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 543
Immunology and clinical importance of antiphospholipid antibodies
McNeil, H. P., Chesterman, C. N., & Krilis, S. A. (1991) · Advances in immunology · doi:10.1016/s0065-2776(08)60777-4 · Cited by 481
Blank, M., Cohen, J., Toder, V, & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 455
Harris, E. N., Gharavi, A. E., & Hughes, G. R. V. (1985) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00606-8 · Cited by 439
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants
Thiagarajan, P., Pengo, V, & Shapiro, S. (1986) · Blood · doi:10.1182/blood.v68.4.869.869 · Cited by 422
Antiphospholipid Antibodies and venous thromboembolism
Ginsberg, J., Wells, P., Brill-Edwards, P., Donovan, D., Moffatt, K., Johnston, M., Stevens, P., & Hirsh, J. (1995) · Blood · doi:10.1182/blood.v86.10.3685.bloodjournal86103685 · Cited by 365
Asherson, R. A., Khamashta, M. A., Gil, A., Vazquez, J.-J., Chan, O., Baguley, E., & Hughes, G. R. V. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90335-5 · Cited by 330
Levine, S. R. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520200078024 · Cited by 301
Prevalence, Follow-Up and Clinical Significance of the Anticardiolipin Antibodies in Normal Subjects
Vila, P., Hernández, M. C., López-Fernández, M. F., & Batlle, J. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1648840 · Cited by 280
Alarcón-Segovia, D., Pérez-Vázquez, M. E., Villa, A. R., Drenkard, C., & Cabiedes, J. (1992) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(92)90021-5 · Cited by 273
Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases
Gastineau, D. A., Kazmier, F. J., Nichols, W. L., & Bowie, E. J. W. (1985) · American Journal of Hematology · doi:10.1002/ajh.2830190308 · Cited by 257
The Relationship Between Lupus Anticoagulants and Antibodies to Phospholipid
Triplett, D. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040042024 · Cited by 252
(2006) · PubMed · Cited by 248
(2004) · PubMed · Cited by 218
Metadata
- Authors
- Elias, M. S.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1984-03-01
- Volume
- 144
- Issue
- 3
- Pages
- 510-510
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1967602919
- Cited by
- 322
- References
- 26
- FWCI
- 29.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.